Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
49.06
Oct 30 • 3:59 PM ET Dollar change+0.31 Percentage change(0.64%)
Aftermarket Close
49.06
Aftermarket • 5:00 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
2.32B
Enterprise Value
4.30B
Income
172.01M
Sales
1.10B
Book/sh
40.46
Cash/sh
1.88
Employees
890
IPO
Feb 10, 2005
P/E
13.74
Forward P/E
9.56
PEG
1.39
P/S
2.10
P/B
1.21
P/C
26.08
P/FCF
9.88
EV/EBITDA
13.34
EV/Sales
3.89
Quick Ratio
1.99
Current Ratio
3.23
Debt/Eq
1.08
LT Debt/Eq
1.07
Option/Short
Yes / Yes
EPS (ttm)
3.57
EPS next Y
5.13
EPS next Q
1.07
EPS this Y
4.66%
EPS next Y
11.95%
EPS next 5Y
6.86%
EPS past 3/5Y
- 3.72%
Sales past 3/5Y
-1.17% 2.91%
EPS Y/Y TTM
-16.45%
Sales Y/Y TTM
-1.36%
EPS Q/Q
-35.65%
Sales Q/Q
6.48%
Insider Own
1.47%
Insider Trans
-0.32%
Inst Own
114.89%
Inst Trans
4.18%
ROA
4.30%
ROE
9.12%
ROIC
4.34%
Gross Margin
51.59%
Oper. Margin
26.26%
Profit Margin
15.57%
SMA20
1.56%
SMA50
1.09%
SMA200
-9.30%
Trades
Shs Outstand
47.37M
Shs Float
46.68M
52W High
71.07 -30.97%
52W Low
42.62 15.11%
Volatility
2.71% 2.85%
ATR (14)
1.48
RSI (14)
54.14
Beta
0.32
Rel Volume
0.66
Avg Volume
561.13K
Volume
371,501
Perf Week
2.64%
Perf Month
9.58%
Perf Quarter
-5.51%
Perf Half Y
-10.95%
Perf YTD
-20.47%
Perf Year
-18.60%
Perf 3Y
-16.73%
Perf 5Y
-18.22%
Perf 10Y
7.07%
Prev Close
48.75
Price
49.06
Change %
0.64%
Consensus
Buy
Avg. Price Target
$67.25
Implied Upside
+37.1%
Analysts9incl. previous ratings
Rating Distribution7 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 14, 2026Downgrade
OPY logoOOppenheimer
Outperform → Perform
Sep 24, 2025Upgrade
SSidoti
Neutral → Buy$80+63.1%
Dec 09, 2024Downgrade
SSidoti
Buy → Neutral$90+83.4%
Jun 21, 2024Upgrade
DDA Davidson
Neutral → Buy$65 → $93+89.6%
Nov 17, 2022Initiated
CCanaccord Genuity
Buy$71+44.7%
May 10, 2022Upgrade
JEF logoJJefferies
Hold → Buy$65 → $70+42.7%
May 09, 2022Upgrade
OPY logoOOppenheimer
Perform → Outperform$63+28.4%
Aug 07, 2020Downgrade
DDA Davidson
Buy → Neutral
Jun 29, 2020Upgrade
SSidoti
Neutral → Buy
Apr 14, 2020Downgrade
JEF logoJJefferies
Buy → Hold
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zerillo JeffreySenior VP OperationsMay 11 '26Sale52.2835118,35041,810May 12 04:01 PM
Zerillo JeffreySenior VP OperationsMay 07 '26Sale54.3630516,58042,161May 11 04:03 PM
Zerillo JeffreyOfficerMay 11 '26Proposed Sale52.2835118,350May 11 09:38 AM
Zerillo JeffreySenior VP OperationsMay 05 '26Sale54.991,20766,37342,820May 07 04:02 PM
Zerillo JeffreyOfficerMay 07 '26Proposed Sale54.3630516,580May 07 02:32 PM
Zerillo JeffreySenior VP OperationsMay 05 '26Sale55.3234619,14144,334May 06 05:16 PM
Zerillo JeffreyOfficerMay 06 '26Proposed Sale54.991,20766,374May 06 12:27 PM
Zerillo JeffreyOfficerMay 05 '26Proposed Sale55.3234619,141May 05 01:03 PM
Zerillo JeffreySenior VP OperationsFeb 11 '26Sale65.931,00065,93041,048Feb 13 04:37 PM
Zerillo JeffreyOfficerFeb 11 '26Proposed Sale65.931,00065,930Feb 11 10:28 AM
Zerillo JeffreySenior VP OperationsNov 28 '25Sale60.0071943,14042,329Dec 02 04:43 PM
Zerillo JeffreySenior VP OperationsDec 01 '25Sale60.0028116,86042,048Dec 02 04:43 PM
Zerillo JeffreyOfficerDec 01 '25Proposed Sale60.0028116,860Dec 01 11:24 AM
Zerillo JeffreyOfficerNov 28 '25Proposed Sale60.0071943,140Nov 28 01:04 PM
BYOM JOHN EDirectorNov 25 '25Sale59.353,000178,05051,594Nov 26 04:01 PM
BYOM JOHN EDirectorNov 25 '25Proposed Sale59.353,000178,050Nov 25 01:08 PM
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
ChairmanMr. Ronald M. Lombardi CPA
CFO & COOMs. Christine Sacco CPA
Senior VPMr. William C. P'Pool J.D.
Executive Vice President of Marketing & SalesMr. Adel Mekhail
Director of Investor RelationsMr. Philip David Terpolilli C.F.A.